Archive · 8 Oct 2026
Five Indian Stocks Soared Despite a Market Sell-Off
The Indian stock market fell over the past year, but some individual companies’ shares rose sharply.
The article looked for companies that met certain size, sales and profitability measures.
Axis Solutions had the biggest rise, at 1,805.2%.
Four other companies also gained, with increases ranging from about 277% to 324%.
The article links their gains to factors such as stronger sales, new products, exports, orders and expanded production.
Their latest reported financial results showed higher revenue or profits.
However, the companies’ share prices have already risen a lot.
Some shares may be expensive compared with similar companies.
The article says investors should watch whether growth continues and consult an adviser before investing; it is not a recommendation.
The Nifty 50 fell 9.4% and the Sensex about 11.2% over the past year, according to the article.
The five screened stocks gained between 277% and 1,805.2%, despite broader market weakness.
Axis Solutions led with a 1,805.2% gain, supported by business growth, orders and expansion plans.
Bhagyanagar India, Modern Insulators, Ind-Swift Laboratories and Venus Remedies reported growth tied to products, exports or capacity.
The article says strong gains do not guarantee future performance and highlights valuations and continued earnings growth as key considerations.
- Who
- Axis Solutions, Bhagyanagar India, Modern Insulators, Ind-Swift Laboratories and Venus Remedies.
- What
- Five stocks gained sharply over the past year despite a weak Indian market.
- When
- Over the past year; the article also cites results for Q1FY27 and FY26.
- Where
- India; the companies also describe business and expansion activity in overseas markets.
- Why
- The article attributes the gains to company-specific factors including business growth, new products, exports, orders and capacity expansion.
Growth case
Caution
Business momentum
Growth case
The article points to stronger financial results, new orders, exports, products and capacity expansion as factors supporting the companies’ share-price gains.
Caution
Past growth and share-price performance do not establish that earnings or returns will continue; the article says execution and future earnings need monitoring.
Valuations
Growth case
Bhagyanagar India and Venus Remedies are described as trading below industry medians on cited valuation measures; Modern Insulators is slightly below its industry P/E median.
Caution
Axis Solutions and Ind-Swift Laboratories have P/E multiples above their industry medians, and the article warns that some stocks have re-rated significantly.
- Market context
- The article reports the Nifty 50 fell 9.4% and the Sensex about 11.2% over the past year.
- Stock gains
- Axis Solutions: 1,805.2%; Bhagyanagar India: 323.6%; Modern Insulators: about 296.6%; Ind-Swift Laboratories: about 296.01%; Venus Remedies: about 277%.
- Screening criteria
- Gains over the past year, market capitalisation above Rs 1,000 crore, sales above Rs 100 crore, and positive three-year average ROE and ROCE; SME stocks and companies with pledged shareholding were excluded.
- Axis Solutions
- Reported Q1 revenue growth of 78% year on year to Rs 48.99 crore and PAT growth of 98% to Rs 3.10 crore.
- Bhagyanagar India
- Reported Q1FY27 revenue growth of 45.2% to Rs 705.1 crore and PAT growth of 167.4% to Rs 20.2 crore.
- Modern Insulators
- Reported Q1FY27 revenue growth of 33.3% to Rs 188 crore and profit doubling to Rs 30 crore.
- Ind-Swift Laboratories and Venus Remedies
- Ind-Swift reported Q1FY27 sales growth of 24.8% to Rs 191 crore and profit growth of 177.8% to Rs 25 crore. Venus reported sales growth of 30.6% to Rs 179 crore and profit of Rs 23 crore, more than double year on year.
- Investment caveat
- The article is for educational purposes, not an investment recommendation, and advises investors to assess growth and valuations and consult an adviser.